Who
Stacy Markel
Chief People Officer
Company insider
Files Form 4 as: Chief People Officer, Nuvation Bio; EVP Human Resources, Rigel Pharmaceuticals.
In numbers
- Trades disclosed
- 23
- Buys
- 1
- Sells
- 1
- Bought
- $17K
- Sold
- $1.5M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Mar 2018
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $169K90,380 at $1.87 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $60K34,620 at $1.74 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $753K125,000 at $6.03 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —90,380 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —34,620 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —90,380 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —34,620 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $169K90,380 at $1.87 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $60K34,620 at $1.74 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $754K125,000 at $6.03 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 18 Jun 2025filed 18 Jun 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Bought | $17K10,000 at $1.71 | filing |
| 28 Feb 2025filed 4 Mar 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 28 Feb 2023filed 2 Mar 2023 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 29 Aug 2022filed 31 Aug 2022 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 28 Feb 2022filed 2 Mar 2022 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 10 Feb 2021filed 12 Feb 2021 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —398,935 | filing |
| 10 Feb 2021filed 12 Feb 2021 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —254,810 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Stacy Markel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.